YuanMing Capital is a private equity firm based in Beijing, China, founded in 2015. Verified contact details, AUM data, and investment preferences on FindLPs.
Yuanming Capital is an investment institution focusing on the pharmaceutical field of China and the United States. The team members have rich business experience and successful investment experience. It has offices in Beijing and New York, and its previous investments cover pharmaceutical research and development, innovative medical device development, and high-end medical service industries in China and the United States.
Investment types: Fund of Funds
Sectors & themes: Biotechnology, Healthcare, Medical Devices & Equipment, Pharmaceuticals
Preferred geographies: Asia, BRIC, Emerging Markets, Greater China, North America, OECD
Location: Room 1106, Tower B, China Waiwen Mansion No.89 North of West Third Ring Road, Haidian District
FindLPs holds verified direct email addresses and phone numbers for decision-makers at YuanMing Capital. Contact details are masked on the free plan — start a plan to unlock full access and CSV export.
Unlock Contact DetailsSearch 25,850 limited partners with verified contact details.
LP firm data compiled from public regulatory filings (SEC Form ADV, FCA, AIFMD disclosures), company websites and press releases, LinkedIn public profiles, and verified outbound email testing. AUM figures reflect self-reported values from filings and may lag by 1–2 fiscal quarters; bands are normalized in USD. We do not publish personal residential information; firms or individuals may request removal at /contact. Methodology & sources · Updated July 2026.